Literature DB >> 18071921

In vitro reactivity and growth inhibition of EPEC serotype O111 and STEC serotypes O111 and O157 by homologous and heterologous chicken egg yolk antibody.

José Araujo Amaral1, Milene Tino De Franco, Lucy Zapata-Quintanilla, Solange Barros Carbonare.   

Abstract

IgY is a chicken egg yolk antibody which has been used for treatment and prophylaxis of gastrointestinal infections. Our aim was to verify if IgY obtained from chickens immunized with EPEC O111, STEC O111 and STEC O157 is able to show in vitro reactivity and biological activity towards the three bacteria. IgY was obtained from eggs laid before and after immunization with each bacterium. The preparations of IgY anti-EPEC O111 and anti-STEC O111 shared high reactivity detected by ELISA and growth inhibition ability towards both bacteria EPEC O111 and STEC O111. Nevertheless, the preparation of IgY anti-STEC O157 showed high reactivity and growth inhibitory effect only towards the homologous strain. Our results showing in vitro biological activity of IgY reinforce its use as an alternative for the treatment or prophylaxis of E. coli infections and encourage the development of in vivo studies for a possible future human therapeutic use.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18071921     DOI: 10.1007/s11259-007-9029-3

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  27 in total

Review 1.  Virulence factors of Escherichia coli O157 and other Shiga toxin-producing E. coli.

Authors:  D Law
Journal:  J Appl Microbiol       Date:  2000-05       Impact factor: 3.772

2.  Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function.

Authors:  B P McNamara; A Koutsouris; C B O'Connell; J P Nougayréde; M S Donnenberg; G Hecht
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

3.  Retention of specific yolk IgY in the human oral cavity.

Authors:  David Carlander; Hans Kollberg; Anders Larsson
Journal:  BioDrugs       Date:  2002       Impact factor: 5.807

4.  Improved Recovery of Immunoglobulin Fraction from Egg Yolk of Chicken Immunized with AsialoGM1.

Authors:  Venkataraman Sriram; Ganesa Yogeeswaran
Journal:  Russ J Immunol       Date:  1999-07

5.  Systemic antibody response to diarrheagenic Escherichia coli and LPS O111, O157 and O55 in healthy Brazilian adults.

Authors:  L B Zapata-Quintanilla; P Palmeira; M Tino-De-Franco; J A Amaral; C B Carbonare; S B Carbonare
Journal:  Scand J Immunol       Date:  2006-12       Impact factor: 3.487

6.  Passive protective effect of chicken egg yolk immunoglobulins against experimental enterotoxigenic Escherichia coli infection in neonatal piglets.

Authors:  H Yokoyama; R C Peralta; R Diaz; S Sendo; Y Ikemori; Y Kodama
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

Review 7.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

8.  Resistance of broiler chickens to Escherichia coli respiratory tract infection induced by passively transferred egg-yolk antibodies.

Authors:  S Kariyawasam; B N Wilkie; C L Gyles
Journal:  Vet Microbiol       Date:  2004-03-05       Impact factor: 3.293

9.  [Etiologic profile of acute diarrhea in children in São Paulo]

Authors:  Eloisa C Souza; Marina B Martinez; Carla R Taddei; Lilian Mukai; Alfredo E Gilio; Maria L Racz; Luzinete Silva; Bernardo Ejzenberg; Yassuhiko Okay
Journal:  J Pediatr (Rio J)       Date:  2002 Jan-Feb       Impact factor: 2.197

Review 10.  Antibodies: an alternative for antibiotics?

Authors:  L R Berghman; D Abi-Ghanem; S D Waghela; S C Ricke
Journal:  Poult Sci       Date:  2005-04       Impact factor: 3.352

View more
  5 in total

1.  Preparation of immunoglobulin Y (IgY) against lipopolysaccharide using gel chromatography from the yolks of eggs laid by immunized hens.

Authors:  Siyuan Ma; Yaping Zhang
Journal:  Protein J       Date:  2010-10       Impact factor: 2.371

2.  IgG Binds Escherichia coli Serine Protease EspP and Protects Mice From E. coli O157:H7 Infection.

Authors:  Ashmita Tontanahal; Vanessa Sperandio; Olga Kovbasnjuk; Sebastian Loos; Ann-Charlotte Kristoffersson; Diana Karpman; Ida Arvidsson
Journal:  Front Immunol       Date:  2022-02-18       Impact factor: 8.786

3.  Growth inhibition of Staphylococcus aureus and escherichia coli strains by neutralizing IgY antibodies from ostrich egg yolk.

Authors:  Fernando Luiz Tobias; Luize Néli Nunes Garcia; Milton Masahiko Kanashiro; Enrique Medina-Acosta; João Gato Brom-de-Luna; Claudia Maria Costa de Almeida; Romildo Rocha Azevedo Junior; Môsar Lemos; Olney Vieira-da-Motta
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

4.  Passive Immune-Protection of Litopenaeus vannamei against Vibrio harveyi and Vibrio parahaemolyticus Infections with Anti-Vibrio Egg Yolk (IgY)-Encapsulated Feed.

Authors:  Xiaojian Gao; Xiaojun Zhang; Li Lin; Dongrui Yao; Jingjing Sun; Xuedi Du; Xiumei Li; Yue Zhang
Journal:  Int J Mol Sci       Date:  2016-05-17       Impact factor: 5.923

5.  Evaluation of Recombinant Attenuated Salmonella Vaccine Strains for Broad Protection against Extraintestinal Pathogenic Escherichia coli.

Authors:  Jacob T Maddux; Zachary R Stromberg; Roy Curtiss Iii; Melha Mellata
Journal:  Front Immunol       Date:  2017-10-09       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.